Acelyrin OverviewAcelyrin EBIT
EBIT (Earnings Before Interest and Taxes) analysis for SLRN.
Quarterly EBIT
-$59.86M
↑ 27.69% YoY
As of Mar 31, 2025
Annual EBIT (TTM)
-$286.66M
↑ 11.81% YoY
Trailing 12 months ending Mar 31, 2025
Acelyrin OverviewEBIT (Earnings Before Interest and Taxes) analysis for SLRN.
As of Mar 31, 2025
Trailing 12 months ending Mar 31, 2025